Focuses on selecting high-probability drug targets by analyzing disease pathophysiology, experimental results, genomics, and pattern recognition to ensure target dependency and therapeutic window.

Involves the design, synthesis, and optimization of new compounds for therapeutic application, leveraging both traditional and new approaches like allostery, covalency, molecular glue, and heterobifunctional degraders.